JUMP — How common sarcopenia and 'chemobrain' are after cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

JUMP is an observational project that brings post-cancer patients to a one-day assessment including standard labs and focused checks for muscle deconditioning and cognitive changes. Participants undergo blood tests (glycaemia, creatinine, liver tests, blood count) and evaluations for sarcopenia and cognitive function. After the assessment day, patients are referred to appropriate local services such as adapted physical activity, sports-for-health programs, or rehabilitation at Henry Gabriel Hospital. The project enrolls adults aged 18–74 with a range of prior cancer types who completed oncology treatment and attended the post-cancer assessment day at Hospices Civils de Lyon.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age : 18 to 74 years
* localization of the primitive: breast, lung, melanoma, testicle, bladder, kidney, ovary, colon and pancreas, hemopathy
* patient who benefited from the post-cancer assessment day-

Exclusion Criteria:

* Under 18years
* Over 74 years
* Patient who did not received any chemical treatment
* Patient who do not wish to participate

Where it's running

• Service de Rhumatologie, Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud
  Pierre-Bénite, France Recruiting

Study contacts

• Study coordinator: Cyrille CONFAVREUX, MD
• Email: Cyrille.confavreux@chu-lyon.fr
• Phone: +334 78 86 12 31

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Sarcopenia in Patients After Cardiac Surgery

  This observational study tests how common sarcopenia is after cardiac surgery and whether current care helps improve muscle mass and function.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven · NCT07908472

• Bone marrow mesenchymal stem cell injection for sarcopenia

  This study tests whether CG-BM1, a stem cell injection, can be safely given to adults with sarcopenia to see if it helps improve muscle health.

  Recruiting Phase 1/2 GuangZhou Cellgenes Biotechnology Co., Ltd. · Guangzhou · NCT07865676

• GLP-1 receptor agonist use and muscle health in adults with obesity without diabetes

  This study tests whether GLP-1 receptor agonists affect muscle mass and strength in adults with obesity who don’t have diabetes.

  Recruiting Istanbul Saglik Bilimleri University · Istanbul, Kucukcekmece · NCT07858864

• Sarcopenia and Epidural Steroid Injections in Lumbar Spinal Stenosis

  We’re testing how sarcopenia relates to pain, function, and quality of life after a routine interlaminar epidural steroid injection in people with lumbar spinal stenosis.

  Recruiting Marmara University · Istanbul, Istanbul · NCT07855419

• Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients

  This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.

  Recruiting Zhangzhou Municipal Hospital · Zhangzhou, Fujian · NCT07836088

• Lower-limb rehabilitation robot training with nutrition education for sarcopenia

  In adults aged 60 and older with sarcopenia, this study tests whether adding robot-assisted leg training to nutrition education can improve muscle mass and walking ability compared with usual care.

  Recruiting Taipei Medical University Hospital · Taipei, Taipei City · NCT07830472

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.